Article
Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Molecular diagnosis & therapy - 1 Jan 2006
Bosch T M, Doodeman V D, Smits P H M, Meijerman I, Schellens J H M, Beijnen J H
Abstract excerpt
BACKGROUND: A possible explanation for the wide interindividual variability in toxicity and efficacy of drug therapy is variation in genes encoding drug-metabolizing enzymes and drug transporters. The allelic frequency of these genetic variants, linkage disequilibrium (LD), and haplotype of these polymorphisms are important parameters in determining the genetic differences between patients. The aim of this study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
